首页 > 最新文献

Rare Tumors最新文献

英文 中文
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort. 接受一线系统疗法的成人肺泡横纹肌肉瘤患者的临床特征和预后:单一机构队列
IF 0.9 Q4 ONCOLOGY Pub Date : 2024-08-04 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241271669
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, Andrew J Bishop, Ravin Ratan, Joseph A Ludwig, Dejka M Araujo, Neeta Somaiah, Vinod Ravi, Elise F Nassif, Christina L Roland, Alexander J Lazar, B Ashleigh Guadagnolo, Douglas J Harrison, Robert S Benjamin, Shreyaskumar R Patel, Anthony P Conley

Background: Rhabdomyosarcomas are the most common soft tissue sarcoma in children, and pediatric alveolar rhabdomyosarcoma (ARMS) prognosis has improved based on cooperative studies. However, in adults, ARMS is significantly rarer, has poorer outcomes, and currently lacks optimal treatment strategies. Objective: This study aimed to evaluate the clinical outcome of an adult ARMS population with different front-line systemic chemotherapies and determine if any chemotherapy regimen is associated with improved survival. Materials and methods: This is a retrospective study of histologically confirmed fusion-positive ARMS patients over 18 years of age, who were treated at MD Anderson Cancer Center (MDACC) from 2004 to 2021 and received systemic chemotherapy. Descriptive clinical statistics were performed, including staging, front-line chemotherapy, multimodal therapy usage, response rates, and survival analyses. Results: 49 ARMS patients who received upfront chemotherapy were identified. Locoregional treatments included radiotherapy (RT) alone (29%, n = 14), surgery alone (10%, n = 5), or both (45%, n = 22). Median overall survival (OS) for the entire cohort was 3.6 years, and the overall response rate to systemic therapy was 89%. No chemotherapy regimen showed OS benefit, specifically analyzing the pediatric-based vincristine, actinomycin-D, cyclophosphamide (VAC) or adult-based vincristine, doxorubicin, ifosfamide (VDI) regimens, even when controlled for other clinical risk factors. Conclusion: In this single-center contemporary series, adult ARMS patient outcomes remain poor. There was no statistically significant OS difference in patients who did or did not receive adult or pediatric based ARMS regimens, although a high overall response rate to chemotherapy was seen across the entire cohort. Based on these observations, further randomized prospective studies are necessary to delineate which frontline chemotherapy regimen is most beneficial in this rare adult cancer.

背景:横纹肌肉瘤是儿童最常见的软组织肉瘤:横纹肌肉瘤是儿童最常见的软组织肉瘤,根据合作研究,小儿肺泡横纹肌肉瘤(ARMS)的预后有所改善。然而,成人横纹肌肉瘤更为罕见,预后较差,目前缺乏最佳治疗策略。研究目的本研究旨在评估采用不同一线全身化疗方案的成人ARMS患者的临床预后,并确定是否有任何化疗方案与生存率的改善相关。材料与方法:这是一项回顾性研究,研究对象为2004年至2021年期间在MD安德森癌症中心(MDACC)接受过系统化疗、组织学确诊为融合阳性的18岁以上ARMS患者。研究进行了描述性临床统计,包括分期、一线化疗、多模式疗法的使用、反应率和生存分析。结果共发现49名接受了前线化疗的ARMS患者。局部治疗包括单纯放疗(RT)(29%,n = 14)、单纯手术(10%,n = 5)或两者(45%,n = 22)。整个组群的中位总生存期(OS)为3.6年,对全身治疗的总反应率为89%。即使在控制了其他临床风险因素的情况下,没有一种化疗方案显示出OS获益,特别是分析了以儿童为基础的长春新碱、放线菌素-D、环磷酰胺(VAC)方案或以成人为基础的长春新碱、多柔比星、伊福法胺(VDI)方案。结论在这一单中心当代系列研究中,成人 ARMS 患者的预后仍然很差。接受或不接受基于成人或儿童的ARMS方案的患者在OS方面没有统计学意义上的显著差异,尽管整个队列中化疗的总体反应率较高。基于这些观察结果,有必要进一步开展随机前瞻性研究,以确定哪种一线化疗方案对这种罕见的成人癌症最有益。
{"title":"Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.","authors":"Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, Andrew J Bishop, Ravin Ratan, Joseph A Ludwig, Dejka M Araujo, Neeta Somaiah, Vinod Ravi, Elise F Nassif, Christina L Roland, Alexander J Lazar, B Ashleigh Guadagnolo, Douglas J Harrison, Robert S Benjamin, Shreyaskumar R Patel, Anthony P Conley","doi":"10.1177/20363613241271669","DOIUrl":"10.1177/20363613241271669","url":null,"abstract":"<p><p><b>Background:</b> Rhabdomyosarcomas are the most common soft tissue sarcoma in children, and pediatric alveolar rhabdomyosarcoma (ARMS) prognosis has improved based on cooperative studies. However, in adults, ARMS is significantly rarer, has poorer outcomes, and currently lacks optimal treatment strategies. <b>Objective:</b> This study aimed to evaluate the clinical outcome of an adult ARMS population with different front-line systemic chemotherapies and determine if any chemotherapy regimen is associated with improved survival. <b>Materials and methods:</b> This is a retrospective study of histologically confirmed fusion-positive ARMS patients over 18 years of age, who were treated at MD Anderson Cancer Center (MDACC) from 2004 to 2021 and received systemic chemotherapy. Descriptive clinical statistics were performed, including staging, front-line chemotherapy, multimodal therapy usage, response rates, and survival analyses. <b>Results:</b> 49 ARMS patients who received upfront chemotherapy were identified. Locoregional treatments included radiotherapy (RT) alone (29%, <i>n</i> = 14), surgery alone (10%, <i>n</i> = 5), or both (45%, <i>n</i> = 22). Median overall survival (OS) for the entire cohort was 3.6 years, and the overall response rate to systemic therapy was 89%. No chemotherapy regimen showed OS benefit, specifically analyzing the pediatric-based vincristine, actinomycin-D, cyclophosphamide (VAC) or adult-based vincristine, doxorubicin, ifosfamide (VDI) regimens, even when controlled for other clinical risk factors. <b>Conclusion:</b> In this single-center contemporary series, adult ARMS patient outcomes remain poor. There was no statistically significant OS difference in patients who did or did not receive adult or pediatric based ARMS regimens, although a high overall response rate to chemotherapy was seen across the entire cohort. Based on these observations, further randomized prospective studies are necessary to delineate which frontline chemotherapy regimen is most beneficial in this rare adult cancer.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241271669"},"PeriodicalIF":0.9,"publicationDate":"2024-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11299201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraventricular schwannomas: A case report and a literature review. 脑室内分裂瘤:病例报告和文献综述
IF 0.9 Q4 ONCOLOGY Pub Date : 2024-07-25 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241267740
Rashid M Hattab, Zeid Jarrar, Sarah Al Sharie, Maysa Al-Hussaini, Mouness Obeidat

Intraventricular schwannomas are extremely rare, typically benign tumors originating from Schwann cells, which are not normally found within the ventricular system. Their presence challenges conventional understanding of tumor origins and complicates diagnosis and management. We report the case of a 19-year-old female presenting with a drop attack and headache, with no significant medical history. MRI revealed a heterogeneously enhancing lesion in the right lateral ventricle. Differential diagnoses included malignant tumors; however, histopathological examination post-surgical resection confirmed an intraventricular schwannoma. Postoperative outcomes were favorable, with successful CSF diversion via a right occipital ventriculoperitoneal shunt for isolated right temporal hydrocephalus. This case is notable for its atypical presentation in a young patient, challenging the conventional understanding that intraventricular schwannomas primarily affect older individuals. In addition, the correct diagnosis and successful management of a rare intraventricular schwannoma underscores the importance of considering this rare diagnosis in patients with nonspecific neurological symptoms and intraventricular lesions. This case, alongside the literature review, enriches the body of evidence on intraventricular schwannomas, highlighting the critical role of surgical intervention and the need for a comprehensive diagnostic approach.

室管膜内分裂瘤是一种极为罕见、典型的良性肿瘤,起源于许旺细胞,通常不存在于脑室系统中。它们的出现挑战了人们对肿瘤起源的传统认识,并使诊断和治疗变得复杂。我们报告了一例 19 岁女性的病例,她因跌倒发作和头痛而就诊,无明显病史。磁共振成像显示右侧侧脑室有异质性增强病变。鉴别诊断包括恶性肿瘤,但手术切除后的组织病理学检查证实为脑室内分裂瘤。术后效果良好,通过右枕脑室腹腔分流术成功地将脑脊液引流至孤立的右颞部脑积水。该病例的显著特点是年轻患者的非典型表现,挑战了室管膜内分裂瘤主要影响老年人的传统认识。此外,对罕见的室管膜内分裂瘤的正确诊断和成功治疗强调了在出现非特异性神经症状和室管膜内病变的患者中考虑这一罕见诊断的重要性。该病例以及文献综述丰富了有关室管膜内分裂瘤的证据,强调了手术干预的关键作用以及综合诊断方法的必要性。
{"title":"Intraventricular schwannomas: A case report and a literature review.","authors":"Rashid M Hattab, Zeid Jarrar, Sarah Al Sharie, Maysa Al-Hussaini, Mouness Obeidat","doi":"10.1177/20363613241267740","DOIUrl":"10.1177/20363613241267740","url":null,"abstract":"<p><p>Intraventricular schwannomas are extremely rare, typically benign tumors originating from Schwann cells, which are not normally found within the ventricular system. Their presence challenges conventional understanding of tumor origins and complicates diagnosis and management. We report the case of a 19-year-old female presenting with a drop attack and headache, with no significant medical history. MRI revealed a heterogeneously enhancing lesion in the right lateral ventricle. Differential diagnoses included malignant tumors; however, histopathological examination post-surgical resection confirmed an intraventricular schwannoma. Postoperative outcomes were favorable, with successful CSF diversion via a right occipital ventriculoperitoneal shunt for isolated right temporal hydrocephalus. This case is notable for its atypical presentation in a young patient, challenging the conventional understanding that intraventricular schwannomas primarily affect older individuals. In addition, the correct diagnosis and successful management of a rare intraventricular schwannoma underscores the importance of considering this rare diagnosis in patients with nonspecific neurological symptoms and intraventricular lesions. This case, alongside the literature review, enriches the body of evidence on intraventricular schwannomas, highlighting the critical role of surgical intervention and the need for a comprehensive diagnostic approach.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241267740"},"PeriodicalIF":0.9,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11273710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of giant retroperitoneal liposarcoma: Case report. 腹膜后巨大脂肪肉瘤的手术治疗:病例报告。
IF 0.9 Q4 ONCOLOGY Pub Date : 2024-07-24 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241266047
Youssef Achour, Youness Bakali, Mahdi Bahij, Hamza Sekkat, Mouna Mhamdi Alaoui, Farid Sabbah, Abdelmalek Hrora, Mohammed Raiss

Tumors originating from soft tissues are uncommon, among these tumors, liposarcomas are the most frequent. These tumors remain asymptomatic for a long time, and only revealing themselves when they reach an important size. In such cases, treatment is difficult, requiring extensive surgery procedures that can excise several adjacent structures, potentially completed by adjuvant radiotherapy. Despite successful treatment, the recurrence rate remains very high. We report the case of a giant liposarcoma requiring a monobloc extensive resection involving the removal of the tumor, left kidney, left adrenal gland, and a portion of the posterior abdominal wall.

源自软组织的肿瘤并不常见,其中最常见的是脂肪肉瘤。这些肿瘤长期无症状,只有在肿瘤达到一定大小时才会显露出来。在这种情况下,治疗十分困难,需要进行广泛的外科手术,切除多个邻近结构,并可能辅以放射治疗。尽管治疗成功,但复发率仍然很高。我们报告了一例巨型脂肪肉瘤病例,该病例需要进行单体广泛切除术,包括切除肿瘤、左肾、左肾上腺和部分后腹壁。
{"title":"Surgical management of giant retroperitoneal liposarcoma: Case report.","authors":"Youssef Achour, Youness Bakali, Mahdi Bahij, Hamza Sekkat, Mouna Mhamdi Alaoui, Farid Sabbah, Abdelmalek Hrora, Mohammed Raiss","doi":"10.1177/20363613241266047","DOIUrl":"10.1177/20363613241266047","url":null,"abstract":"<p><p>Tumors originating from soft tissues are uncommon, among these tumors, liposarcomas are the most frequent. These tumors remain asymptomatic for a long time, and only revealing themselves when they reach an important size. In such cases, treatment is difficult, requiring extensive surgery procedures that can excise several adjacent structures, potentially completed by adjuvant radiotherapy. Despite successful treatment, the recurrence rate remains very high. We report the case of a giant liposarcoma requiring a monobloc extensive resection involving the removal of the tumor, left kidney, left adrenal gland, and a portion of the posterior abdominal wall.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241266047"},"PeriodicalIF":0.9,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11271108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enormous myxoid/round cell liposarcoma: A case report. 巨大肌样/圆形细胞脂肪肉瘤:病例报告
IF 0.9 Q4 Medicine Pub Date : 2024-05-16 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241255668
Joshua R Finlay, Gayathri Vijayakumar, Ankica Braun, Abdullah Almajnooni, Austin Yu, Ira Miller, George Kokosis, Dian Wang, Alan Blank, Steven Gitelis

Myxoid/round cell liposarcomas (MRCLPS) are a rare soft tissue sarcoma. We report the largest sarcoma in our institutional history. We discuss the patient's surgical management and treatment of the tumor and challenges given its dimensions. Several complications arose following primary resection that were managed by a multidisciplinary team. Although MRCLPS can vary in size, large MRCLPS must be treated cautiously given the potential for complications. Additionally, multidisciplinary treatment of MRCLPS is essential in diagnosing and treating these complex cases.

类肉瘤/圆形细胞脂肪肉瘤(MRCLPS)是一种罕见的软组织肉瘤。我们报告了本院历史上最大的肉瘤。我们讨论了患者的手术管理、肿瘤的治疗以及肿瘤巨大所带来的挑战。初级切除术后出现了一些并发症,多学科团队对这些并发症进行了处理。虽然 MRCLPS 的大小不一,但考虑到并发症的可能性,大的 MRCLPS 必须谨慎治疗。此外,多学科治疗 MRCLPS 对于诊断和治疗这些复杂病例至关重要。
{"title":"Enormous myxoid/round cell liposarcoma: A case report.","authors":"Joshua R Finlay, Gayathri Vijayakumar, Ankica Braun, Abdullah Almajnooni, Austin Yu, Ira Miller, George Kokosis, Dian Wang, Alan Blank, Steven Gitelis","doi":"10.1177/20363613241255668","DOIUrl":"10.1177/20363613241255668","url":null,"abstract":"<p><p>Myxoid/round cell liposarcomas (MRCLPS) are a rare soft tissue sarcoma. We report the largest sarcoma in our institutional history. We discuss the patient's surgical management and treatment of the tumor and challenges given its dimensions. Several complications arose following primary resection that were managed by a multidisciplinary team. Although MRCLPS can vary in size, large MRCLPS must be treated cautiously given the potential for complications. Additionally, multidisciplinary treatment of MRCLPS is essential in diagnosing and treating these complex cases.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241255668"},"PeriodicalIF":0.9,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gigantic laryngeal schwannoma: A case report with literature review. 巨大喉分裂瘤:病例报告与文献综述。
IF 0.9 Q4 Medicine Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241255669
Daniel Nguyen, Nyein Nyein Htun, Cary Johnson

Laryngeal schwannoma is a rare benign nerve sheath tumor that is slow growing. The diagnosis is made from a combination of clinical, radiological, and histopathological findings, and the main method of treatment is resection. We report a case of a 69-year-old presenting with a neck mass causing stridor, dysphagia, and orthopnea. CT of the neck showed an enhancing mass measuring 6.3 cm and extending superior to the larynx. Emergent tracheostomy and mass resection were performed, and histopathology and immunohistochemical findings were obtained from the specimen supporting schwannoma. In conclusion, while rare, schwannoma should always be considered as a differential diagnosis for a laryngeal mass. More studies are needed to assess the size and prognosis of the tumor.

喉分裂瘤是一种罕见的良性神经鞘瘤,生长缓慢。诊断需要结合临床、放射学和组织病理学检查结果,主要治疗方法是切除。我们报告了一例 69 岁患者的病例,该患者因颈部肿块导致呼吸困难、吞咽困难和呼吸暂停。颈部 CT 显示肿块增大,大小为 6.3 厘米,延伸至喉部上方。医生紧急进行了气管造口术和肿块切除术,并从标本中获得了组织病理学和免疫组化结果,证实为分裂瘤。总之,尽管精神分裂瘤很罕见,但应始终将其作为喉肿块的鉴别诊断。需要进行更多的研究来评估肿瘤的大小和预后。
{"title":"Gigantic laryngeal schwannoma: A case report with literature review.","authors":"Daniel Nguyen, Nyein Nyein Htun, Cary Johnson","doi":"10.1177/20363613241255669","DOIUrl":"https://doi.org/10.1177/20363613241255669","url":null,"abstract":"<p><p>Laryngeal schwannoma is a rare benign nerve sheath tumor that is slow growing. The diagnosis is made from a combination of clinical, radiological, and histopathological findings, and the main method of treatment is resection. We report a case of a 69-year-old presenting with a neck mass causing stridor, dysphagia, and orthopnea. CT of the neck showed an enhancing mass measuring 6.3 cm and extending superior to the larynx. Emergent tracheostomy and mass resection were performed, and histopathology and immunohistochemical findings were obtained from the specimen supporting schwannoma. In conclusion, while rare, schwannoma should always be considered as a differential diagnosis for a laryngeal mass. More studies are needed to assess the size and prognosis of the tumor.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241255669"},"PeriodicalIF":0.9,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory epithelial adenomatoid hamartoma: A rare differential diagnosis of sinonasal mass. 呼吸道上皮腺瘤样火腿肠瘤:鼻窦肿块的罕见鉴别诊断。
IF 0.9 Q4 Medicine Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241255567
Safa Nefzaoui, Imen Zoghlami, Jihene Gharsalli, Emna Sabehi, Nadia Romdhane, Imen Helal, Dorra Chiboub, Ines Hariga, Chiraz Mbarek

Sino-nasal respiratory epithelial adenomatoid hamartomas (REAHs) are rare entity. They are benign tumors with excellent results after complete excision. We report a case of a 57-year-old male with a history of endoscopic surgery for right nasal polyps 20 years ago. The patient presented nasal obstruction that persisted for 10 years without anosmia nor epistaxis. Nasal endoscopy found a tissular mass filling the right nasal cavity extending to the nasopharynx. CT scan and MRI demonstrated soft tissue opacification of the right maxillary sinus and the homolateral anterior ethmoid cells with extension to the nasal cavity. The suspected diagnosis on imaging was an Inverted papilloma with a wide implantation base on the posterior part of the nasal septum. No endocranial or orbital extension was noted. The patient underwent endoscopic sinus surgery with complete extirpation of the tumor and a right ethmoidectomy. Histopathological assessment showed features consistent with REAH. No recurrence was noted at 1 year follow-up.

中鼻呼吸道上皮腺瘤样火腿瘤(REAHs)是一种罕见的肿瘤。它们是良性肿瘤,完全切除后效果极佳。我们报告了一例 57 岁男性患者的病例,患者 20 年前曾因右鼻息肉接受过鼻内镜手术。患者的鼻塞症状持续了 10 年,既无嗅觉也无鼻衄。鼻内窥镜检查发现,右侧鼻腔充满了一个组织块,一直延伸到鼻咽部。CT 扫描和核磁共振成像显示右侧上颌窦和同侧前乙状腺细胞软组织不透明,并延伸至鼻腔。影像学疑似诊断为倒置乳头状瘤,鼻中隔后部植入基底较宽。未发现颅内或眼眶扩展。患者接受了内窥镜鼻窦手术,完全切除了肿瘤,并进行了右侧乙状结肠切除术。组织病理学评估显示其特征与 REAH 一致。随访一年未发现复发。
{"title":"Respiratory epithelial adenomatoid hamartoma: A rare differential diagnosis of sinonasal mass.","authors":"Safa Nefzaoui, Imen Zoghlami, Jihene Gharsalli, Emna Sabehi, Nadia Romdhane, Imen Helal, Dorra Chiboub, Ines Hariga, Chiraz Mbarek","doi":"10.1177/20363613241255567","DOIUrl":"https://doi.org/10.1177/20363613241255567","url":null,"abstract":"<p><p>Sino-nasal respiratory epithelial adenomatoid hamartomas (REAHs) are rare entity. They are benign tumors with excellent results after complete excision. We report a case of a 57-year-old male with a history of endoscopic surgery for right nasal polyps 20 years ago. The patient presented nasal obstruction that persisted for 10 years without anosmia nor epistaxis. Nasal endoscopy found a tissular mass filling the right nasal cavity extending to the nasopharynx. CT scan and MRI demonstrated soft tissue opacification of the right maxillary sinus and the homolateral anterior ethmoid cells with extension to the nasal cavity. The suspected diagnosis on imaging was an Inverted papilloma with a wide implantation base on the posterior part of the nasal septum. No endocranial or orbital extension was noted. The patient underwent endoscopic sinus surgery with complete extirpation of the tumor and a right ethmoidectomy. Histopathological assessment showed features consistent with REAH. No recurrence was noted at 1 year follow-up.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241255567"},"PeriodicalIF":0.9,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of pediatric extracranial germ cell tumors: A single center experience in a developing country. 小儿颅外生殖细胞瘤的治疗效果:发展中国家单个中心的经验。
IF 0.9 Q4 ONCOLOGY Pub Date : 2024-04-01 eCollection Date: 2024-01-01 DOI: 10.1177/20363613231216567
Symbat Saliyeva, Riza Boranbayeva, Minira Bulegenova, Bakhram Zhumadullayev, Gaukhar Nurzhanova, Lyazat Manzhuova

The purpose of this study was to analyze the outcomes of extracranial GCT in children in a developing country and to assess prognostic factors. The data on 141 children (<18 years old) with extracranial GCT, confirmed histopathologically, collected over the past 9 years (from February 2013 to June 2022) were retrospectively studied. The patients underwent the same therapy with platinum-containing chemotherapy regimens. In the malignant GCT group, OS and EFS were 81.0 ± 4% and 73 ± 5%, respectively. OS and EFS in the teratoma group were 90 ± 5% and 85 ± 6%. In univariate analysis, parameters like stage of disease, tumor localization, AFP level ≥10,000 ng/mL, serum AFP kinetics and resection status were found to be statistically significant prognostic factors. In the multivariate analysis, the significant adverse factors were the resection status, initial AFP level ≥10,000 ng/mL and serum AFP kinetics slow down (p = .000). Good survival rates can be achieved in developing countries with adequate compliance with treatment protocols. The analysis demonstrates high efficacy of platinum-containing chemotherapy regimens. In our opinion, the protocol used in high-income countries can be implemented in low-income countries with the financial support from the government. The qualification of specialists is also important.

本研究旨在分析发展中国家儿童颅外 GCT 的预后情况,并评估预后因素。141名儿童的数据(P = .000)。在发展中国家,只要充分遵守治疗方案,就能实现良好的存活率。分析表明,含铂化疗方案的疗效很高。我们认为,在政府的财政支持下,高收入国家使用的方案可以在低收入国家实施。专家的资质也很重要。
{"title":"Outcomes of pediatric extracranial germ cell tumors: A single center experience in a developing country.","authors":"Symbat Saliyeva, Riza Boranbayeva, Minira Bulegenova, Bakhram Zhumadullayev, Gaukhar Nurzhanova, Lyazat Manzhuova","doi":"10.1177/20363613231216567","DOIUrl":"https://doi.org/10.1177/20363613231216567","url":null,"abstract":"<p><p>The purpose of this study was to analyze the outcomes of extracranial GCT in children in a developing country and to assess prognostic factors. The data on 141 children (<18 years old) with extracranial GCT, confirmed histopathologically, collected over the past 9 years (from February 2013 to June 2022) were retrospectively studied. The patients underwent the same therapy with platinum-containing chemotherapy regimens. In the malignant GCT group, OS and EFS were 81.0 ± 4% and 73 ± 5%, respectively. OS and EFS in the teratoma group were 90 ± 5% and 85 ± 6%. In univariate analysis, parameters like stage of disease, tumor localization, AFP level ≥10,000 ng/mL, serum AFP kinetics and resection status were found to be statistically significant prognostic factors. In the multivariate analysis, the significant adverse factors were the resection status, initial AFP level ≥10,000 ng/mL and serum AFP kinetics slow down (<i>p</i> = .000). Good survival rates can be achieved in developing countries with adequate compliance with treatment protocols. The analysis demonstrates high efficacy of platinum-containing chemotherapy regimens. In our opinion, the protocol used in high-income countries can be implemented in low-income countries with the financial support from the government. The qualification of specialists is also important.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613231216567"},"PeriodicalIF":0.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ewing's sarcoma of the parotid gland: A rare entity with review of the literature. 腮腺尤文氏肉瘤:罕见病例及文献综述
IF 0.9 Q4 Medicine Pub Date : 2024-03-28 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241242570
Hayfa Chahdoura, Alia Mousli, Ghaiet El Fidaa Noubigh, Safia Yahyaoui, Rim Abidi, Nasr Chiraz

Background: Ewing's sarcoma is a rare malignant entity. Extraosseous Ewing's sarcoma (EES) of the head and neck region is a rare occurrence, and Ewing's sarcoma of the parotid gland is even rarer. To the best of our knowledge, we reported the first case of extraskeletal ES originating from the parotid gland in the Tunisian literature.

Case report: We report a rare case of EES of the parotid gland in a 35-year-old female. She presented with left parotid tumefaction. Physical examination revealed solid and fixed mass associated with facial paralysis. Magnetic resonance imaging illustrated a left intra-parotid process occupying the entire gland measuring 42 mm infiltrating the masseter and pterygoid muscles. The patient had a total left parotidectomy with ipsilateral triangular lymph node dissection. The definitive pathological examination and the immunohistochemical staining confirmed a primary peripheral neuroectodermal tumor or PNET with the presence of a specific EWING/PNET-type translocation in 60% of the tumor cells. She had an adjuvant chemotherapy (four cycles of vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide) followed by external radiotherapy.

Conclusion: A clinical and radiological follow-up by cervical MRI was done every 3 months and The 10-month follow-up showed no locoregional and distant recurrence.

背景:尤文氏肉瘤是一种罕见的恶性肿瘤:尤文氏肉瘤是一种罕见的恶性肿瘤。头颈部骨外尤文氏肉瘤(EES)非常罕见,而腮腺尤文氏肉瘤则更为罕见。据我们所知,在突尼斯的文献中,我们报告了首例源于腮腺的骨骼外 EES:我们报告了一例罕见的腮腺 ES 病例,患者是一名 35 岁的女性。她出现左侧腮腺肿瘤。体检发现实性固定肿块,伴有面瘫。磁共振成像显示,左侧腮腺内肿物占据整个腺体,大小为42毫米,浸润颌下肌和翼状肌。患者接受了左侧腮腺全切除术和同侧三角淋巴结清扫术。最终的病理检查和免疫组化染色证实这是一种原发性周围神经外胚层肿瘤或 PNET,60% 的肿瘤细胞存在特异性 EWING/PNET 型易位。她接受了辅助化疗(长春新碱、多柔比星、环磷酰胺与伊佛酰胺和依托泊苷交替使用四个周期),随后接受了体外放疗:每 3 个月通过宫颈核磁共振进行一次临床和放射学随访,10 个月的随访显示没有局部和远处复发。
{"title":"Ewing's sarcoma of the parotid gland: A rare entity with review of the literature.","authors":"Hayfa Chahdoura, Alia Mousli, Ghaiet El Fidaa Noubigh, Safia Yahyaoui, Rim Abidi, Nasr Chiraz","doi":"10.1177/20363613241242570","DOIUrl":"10.1177/20363613241242570","url":null,"abstract":"<p><strong>Background: </strong>Ewing's sarcoma is a rare malignant entity. Extraosseous Ewing's sarcoma (EES) of the head and neck region is a rare occurrence, and Ewing's sarcoma of the parotid gland is even rarer. To the best of our knowledge, we reported the first case of extraskeletal ES originating from the parotid gland in the Tunisian literature.</p><p><strong>Case report: </strong>We report a rare case of EES of the parotid gland in a 35-year-old female. She presented with left parotid tumefaction. Physical examination revealed solid and fixed mass associated with facial paralysis. Magnetic resonance imaging illustrated a left intra-parotid process occupying the entire gland measuring 42 mm infiltrating the masseter and pterygoid muscles. The patient had a total left parotidectomy with ipsilateral triangular lymph node dissection. The definitive pathological examination and the immunohistochemical staining confirmed a primary peripheral neuroectodermal tumor or PNET with the presence of a specific EWING/PNET-type translocation in 60% of the tumor cells. She had an adjuvant chemotherapy (four cycles of vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide) followed by external radiotherapy.</p><p><strong>Conclusion: </strong>A clinical and radiological follow-up by cervical MRI was done every 3 months and The 10-month follow-up showed no locoregional and distant recurrence.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241242570"},"PeriodicalIF":0.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spindle cell carcinomaof the larynx: A case report and literature review. 喉部纺锤形细胞癌:病例报告和文献综述。
IF 0.9 Q4 Medicine Pub Date : 2024-03-27 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241242705
Alia Mousli, Ferdaous Friaa, Emna Boudhina, Selma Kamoun, Rim Abidi, Chiraz Nasr

Introduction: Spindle cell carcinoma (SCC), also called sarcomatoid carcinoma or carcinosarcoma, represents a rare variant of squamous cell carcinoma that may involve multiple organs, including the larynx. It is a mixed tumor, composed of both malignant epithelial and mesenchymal elements. As the larynx appears to be an unusual site, we report a case of treated SCC laryngeal as well as a literature review of such tumor.

Observation: A 72-year-old male, with 2 months' history of a progressive worsening dysphonia, was examined. The patient examination showed no cervical adenopathy, while direct laryngoscopy detected a voluminous budding formation of the anterior commissure. A biopsy was performed, in which an undifferentiated carcinoma was identified. The computed tomography (CT) confirmed the existence of a glottic tumor, which completely obstructs the lumen of the larynx. No metastasis were noticed elsewhere on the PET-CT. The tumor was then classified as T3 N0 M0. The patient underwent a total laryngectomy, thyroidectomy and neck dissection. The definitive histopathological analysis confirmed the diagnosis of SCC of the larynx with negative surgical margins. Afterward, the patient underwent adjuvant radiotherapy (RT) on the tumor bed.

Conclusion: Primary laryngeal SCC is a very rare malignancy with a tendency to occur with controlateral lymph node metastasis at an early stage of the disease. Combining surgery and postoperative RT is recommended due to its aggressive profile.

简介纺锤形细胞癌(SCC)又称肉瘤样癌或癌肉瘤,是鳞状细胞癌的一种罕见变种,可累及包括喉部在内的多个器官。它是一种混合肿瘤,由恶性上皮细胞和间质细胞组成。由于喉部似乎是一个不常见的部位,我们报告了一例经过治疗的喉部 SCC,并对此类肿瘤进行了文献综述:患者为一名 72 岁男性,因发音障碍进行性加重已有 2 个月病史。患者的检查结果显示没有颈部腺病,而直接喉镜检查则发现前会厌有大量萌芽形成。对患者进行了活组织检查,发现是未分化癌。计算机断层扫描(CT)证实了声门肿瘤的存在,肿瘤完全阻塞了喉腔。PET-CT 检查未发现其他部位的转移。肿瘤被归类为 T3 N0 M0。患者接受了全喉切除术、甲状腺切除术和颈部切除术。最终组织病理分析确诊为喉癌,手术切缘阴性。随后,患者接受了肿瘤床辅助放疗(RT):原发性喉SCC是一种非常罕见的恶性肿瘤,在疾病的早期阶段容易发生控制侧淋巴结转移。由于其侵袭性较强,建议将手术和术后 RT 结合使用。
{"title":"Spindle cell carcinomaof the larynx: A case report and literature review.","authors":"Alia Mousli, Ferdaous Friaa, Emna Boudhina, Selma Kamoun, Rim Abidi, Chiraz Nasr","doi":"10.1177/20363613241242705","DOIUrl":"10.1177/20363613241242705","url":null,"abstract":"<p><strong>Introduction: </strong>Spindle cell carcinoma (SCC), also called sarcomatoid carcinoma or carcinosarcoma, represents a rare variant of squamous cell carcinoma that may involve multiple organs, including the larynx. It is a mixed tumor, composed of both malignant epithelial and mesenchymal elements. As the larynx appears to be an unusual site, we report a case of treated SCC laryngeal as well as a literature review of such tumor.</p><p><strong>Observation: </strong>A 72-year-old male, with 2 months' history of a progressive worsening dysphonia, was examined. The patient examination showed no cervical adenopathy, while direct laryngoscopy detected a voluminous budding formation of the anterior commissure. A biopsy was performed, in which an undifferentiated carcinoma was identified. The computed tomography (CT) confirmed the existence of a glottic tumor, which completely obstructs the lumen of the larynx. No metastasis were noticed elsewhere on the PET-CT. The tumor was then classified as T3 N0 M0. The patient underwent a total laryngectomy, thyroidectomy and neck dissection. The definitive histopathological analysis confirmed the diagnosis of SCC of the larynx with negative surgical margins. Afterward, the patient underwent adjuvant radiotherapy (RT) on the tumor bed.</p><p><strong>Conclusion: </strong>Primary laryngeal SCC is a very rare malignancy with a tendency to occur with controlateral lymph node metastasis at an early stage of the disease. Combining surgery and postoperative RT is recommended due to its aggressive profile.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241242705"},"PeriodicalIF":0.9,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extra-gastrointestinal stromal tumour of the lesser omentum presenting as a massive intra-abdominal swelling: A case report and literature review. 表现为腹内巨大肿物的小网膜胃肠道外间质瘤:病例报告和文献综述。
IF 0.9 Q4 ONCOLOGY Pub Date : 2024-03-27 eCollection Date: 2024-01-01 DOI: 10.1177/20363613241242572
John Adi Ashindoitiang, Victor Ikechukwu Canice Nwagbara, Theophilus Ipeh Ugbem, Nkami Joseph Enya, Ikechimka Ogbugbanduchi Aniebo, Joseph Christopher Ekong, Sidney Esotu Obinna, Maurice Efana Asuquo

Extra gastrointestinal stromal tumour(EGIST) is rare and is regarded as gastrointestinal stromal tumour(GIST) that originates outside of the gastrointestinal tract. They originate from other intraabdominal tissues such as the omentum, mesentery and peritoneum. The cell of origin is the interstitial cell of Cajal(ICC), a pacemaker cell that controls gastrointestinal peristalsis and the tumor is characterized by the expression of KIT(CD117) a transmembrane tyrosine kinase receptor. Here, a 49-year-old female who presented with a 6 month history of abdominal pain, progressive abdominal swelling and the presence of an upper abdominal mass. She had surgical resection and adjuvant imatinib for the intraabdominal mass diagnosed on histology and immunohistochemistry as EGIST of the lesser omentum. Serial CT 14 months after surgery revealed no evidence of recurrence or metastasis. Clinicians should consider EGIST in the differential diagnosis of abdominal masses.

胃肠道外间质瘤(EGIST)很罕见,被视为起源于胃肠道外的胃肠道间质瘤(GIST)。它们起源于网膜、肠系膜和腹膜等其他腹腔内组织。肿瘤的起源细胞是卡贾尔间质细胞(ICC),这是一种控制胃肠蠕动的起搏细胞,其特征是表达跨膜酪氨酸激酶受体 KIT(CD117)。这里有一位 49 岁的女性患者,6 个月前出现腹痛、进行性腹部肿胀和上腹部肿块。经组织学和免疫组化确诊为小网膜EGIST,她接受了手术切除和伊马替尼辅助治疗。术后 14 个月的连续 CT 检查未发现复发或转移迹象。临床医生在鉴别诊断腹部肿块时应考虑 EGIST。
{"title":"Extra-gastrointestinal stromal tumour of the lesser omentum presenting as a massive intra-abdominal swelling: A case report and literature review.","authors":"John Adi Ashindoitiang, Victor Ikechukwu Canice Nwagbara, Theophilus Ipeh Ugbem, Nkami Joseph Enya, Ikechimka Ogbugbanduchi Aniebo, Joseph Christopher Ekong, Sidney Esotu Obinna, Maurice Efana Asuquo","doi":"10.1177/20363613241242572","DOIUrl":"10.1177/20363613241242572","url":null,"abstract":"<p><p>Extra gastrointestinal stromal tumour(EGIST) is rare and is regarded as gastrointestinal stromal tumour(GIST) that originates outside of the gastrointestinal tract. They originate from other intraabdominal tissues such as the omentum, mesentery and peritoneum. The cell of origin is the interstitial cell of Cajal(ICC), a pacemaker cell that controls gastrointestinal peristalsis and the tumor is characterized by the expression of KIT(CD117) a transmembrane tyrosine kinase receptor. Here, a 49-year-old female who presented with a 6 month history of abdominal pain, progressive abdominal swelling and the presence of an upper abdominal mass. She had surgical resection and adjuvant imatinib for the intraabdominal mass diagnosed on histology and immunohistochemistry as EGIST of the lesser omentum. Serial CT 14 months after surgery revealed no evidence of recurrence or metastasis. Clinicians should consider EGIST in the differential diagnosis of abdominal masses.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"16 ","pages":"20363613241242572"},"PeriodicalIF":0.9,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rare Tumors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1